Adicet Bio, Inc. Income Taxes Paid
Adicet Bio, Inc. (ACET) reported Income Taxes Paid of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2023-03-15
- Adicet Bio, Inc. income taxes paid for the quarter ending 2020-12-31 was $0.00.
- Adicet Bio, Inc. income taxes paid for the quarter ending 2019-12-31 was $0.00.
- Adicet Bio, Inc. income taxes paid for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Adicet Bio, Inc. income taxes paid for fiscal 2021 was $43.00K, a 1333.33% increase from fiscal 2020.
- Adicet Bio, Inc. income taxes paid for fiscal 2020 was $3.00K, a 200.00% increase from fiscal 2019.
- Adicet Bio, Inc. income taxes paid for fiscal 2019 was $1.00K, a 99.98% decline from fiscal 2018.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month | Income Taxes Paid 12 month as first filed |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-15 | |||
| 2021-12-31 | $43.00K 10-K · filed 2023-03-15 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $3.00K 10-K · filed 2022-03-15 | ||
| 2020-09-30 | $3.00K 10-Q · filed 2020-11-05 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.00K 10-K · filed 2021-03-12 | $62.00K 10-K · filed 2020-03-12 | |
| 2019-09-30 | $1.00K 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $5.11M 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |